Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kaern

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Acta Ophthalmologica|December 1, 1983
A study of inclusion conjunctivitis in newborn and young adults. Clinical picture, culture, conjunctival scrapings and cytology of the tear fluid in 12 casesI L Mølgaard, P B Nielsen, J Kaern
Obstetrics and Gynecology|July 1, 1985
Intrauterine growth in twin pregnancies: prediction of fetal growth retardationN J Secher, J Kaern, P K Hansen
European Journal of Gynaecological Oncology|August 15, 2001
Long-term results from a phase II study of paclitaxel combined with doxorubicin in recurrent platinum refractory ovarian cancerC Tropé, G Kristensen, J Kisic, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1976
Clinical experience with the REDY dialysis systemH Jans, J Kaern, B Nielsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 18, 2000
[DNA ploidy in epithelial ovarian cancer--an independent prognostic factor]C G Tropé, V Abeler, M Baekelandt, et al.
Gynecologic Oncology|March 1, 1996
Cisplatin/5-fluorouracil treatment of recurrent cervical carcinoma: a phase II study with long-term follow-upJ Kaern, C Tropé, K Sundfoer, et al.
Gynecologic Oncology|August 1, 1992
Bleomycin-ifosfamide-cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second lookK Ramm, I B Vergote, J Kaern, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 1, 1993
DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovaryJ. Kaern, C.G. Tropé, G.B. Kristensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1997
Paclitaxel in untreated FIGO stage III suboptimally resected ovarian cancerC Tropé, J Kaern, G Kristensen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 9, 2001
[Examination, treatment and follow-up of ovarian cancer in Norway]T Paulsen, K Kjaerheim, J Kaern, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Acta Ophthalmologica|December 1, 1983
A study of inclusion conjunctivitis in newborn and young adults. Clinical picture, culture, conjunctival scrapings and cytology of the tear fluid in 12 casesI L Mølgaard, P B Nielsen, J Kaern
Obstetrics and Gynecology|July 1, 1985
Intrauterine growth in twin pregnancies: prediction of fetal growth retardationN J Secher, J Kaern, P K Hansen
European Journal of Gynaecological Oncology|August 15, 2001
Long-term results from a phase II study of paclitaxel combined with doxorubicin in recurrent platinum refractory ovarian cancerC Tropé, G Kristensen, J Kisic, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1976
Clinical experience with the REDY dialysis systemH Jans, J Kaern, B Nielsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 18, 2000
[DNA ploidy in epithelial ovarian cancer--an independent prognostic factor]C G Tropé, V Abeler, M Baekelandt, et al.
Gynecologic Oncology|March 1, 1996
Cisplatin/5-fluorouracil treatment of recurrent cervical carcinoma: a phase II study with long-term follow-upJ Kaern, C Tropé, K Sundfoer, et al.
Gynecologic Oncology|August 1, 1992
Bleomycin-ifosfamide-cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second lookK Ramm, I B Vergote, J Kaern, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 1, 1993
DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovaryJ. Kaern, C.G. Tropé, G.B. Kristensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1997
Paclitaxel in untreated FIGO stage III suboptimally resected ovarian cancerC Tropé, J Kaern, G Kristensen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 9, 2001
[Examination, treatment and follow-up of ovarian cancer in Norway]T Paulsen, K Kjaerheim, J Kaern, et al.
Pageof 7